cladribine has been researched along with Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan, DL; Eastlund, T; Long-Tsai, M; Peterson, BA | 1 |
| Błasińska-Morawiec, M; Hellmann, A; Konopka, L; Krykowski, E; Robak, T | 1 |
2 other study(ies) available for cladribine and Hemolysis
| Article | Year |
|---|---|
Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Autoantibodies; Cladribine; Erythrocytes; Hemolysis; Humans; Immunoglobulin G; Male; Middle Aged; Waldenstrom Macroglobulinemia | 2006 |
Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine).
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antigens, CD; Antineoplastic Agents; B-Lymphocytes; Cladribine; Coombs Test; Female; Hemolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Retrospective Studies | 1997 |